nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—DRD3—telencephalic ventricle—malignant glioma	0.08	0.124	CbGeAlD
Amisulpride—HTR2A—choroid plexus—malignant glioma	0.0762	0.119	CbGeAlD
Amisulpride—HTR7—pons—malignant glioma	0.0435	0.0677	CbGeAlD
Amisulpride—HTR2A—cerebellar cortex—malignant glioma	0.0384	0.0597	CbGeAlD
Amisulpride—HTR7—telencephalic ventricle—malignant glioma	0.0358	0.0557	CbGeAlD
Amisulpride—DRD2—telencephalic ventricle—malignant glioma	0.0339	0.0526	CbGeAlD
Amisulpride—HTR2A—pons—malignant glioma	0.0271	0.0422	CbGeAlD
Amisulpride—HTR2A—vertebral column—malignant glioma	0.0269	0.0419	CbGeAlD
Amisulpride—HTR2A—telencephalic ventricle—malignant glioma	0.0223	0.0347	CbGeAlD
Amisulpride—HTR2A—pineal body—malignant glioma	0.0194	0.0301	CbGeAlD
Amisulpride—HTR7—endothelium—malignant glioma	0.0192	0.0299	CbGeAlD
Amisulpride—HTR7—blood vessel—malignant glioma	0.0177	0.0276	CbGeAlD
Amisulpride—Deep vein thrombosis—Temozolomide—malignant glioma	0.0147	0.0427	CcSEcCtD
Amisulpride—Hypokinesia—Carmustine—malignant glioma	0.0137	0.0398	CcSEcCtD
Amisulpride—HTR2A—endothelium—malignant glioma	0.012	0.0186	CbGeAlD
Amisulpride—Extrapyramidal disorder—Temozolomide—malignant glioma	0.0118	0.0345	CcSEcCtD
Amisulpride—HTR2A—blood vessel—malignant glioma	0.0111	0.0172	CbGeAlD
Amisulpride—Sulpiride—BCHE—malignant glioma	0.011	1	CrCbGaD
Amisulpride—DRD3—central nervous system—malignant glioma	0.0109	0.017	CbGeAlD
Amisulpride—Endocrine disorder—Temozolomide—malignant glioma	0.0108	0.0313	CcSEcCtD
Amisulpride—Breast pain—Temozolomide—malignant glioma	0.0102	0.0298	CcSEcCtD
Amisulpride—Amenorrhoea—Temozolomide—malignant glioma	0.0102	0.0296	CcSEcCtD
Amisulpride—HTR2B—telencephalon—malignant glioma	0.01	0.0156	CbGeAlD
Amisulpride—HTR7—brainstem—malignant glioma	0.00969	0.0151	CbGeAlD
Amisulpride—Pulmonary embolism—Carmustine—malignant glioma	0.00923	0.0269	CcSEcCtD
Amisulpride—DRD2—brainstem—malignant glioma	0.00916	0.0142	CbGeAlD
Amisulpride—Vaginal inflammation—Temozolomide—malignant glioma	0.00892	0.026	CcSEcCtD
Amisulpride—Pulmonary embolism—Temozolomide—malignant glioma	0.00892	0.026	CcSEcCtD
Amisulpride—DRD2—retina—malignant glioma	0.00884	0.0137	CbGeAlD
Amisulpride—DRD3—brain—malignant glioma	0.00867	0.0135	CbGeAlD
Amisulpride—HTR7—telencephalon—malignant glioma	0.0086	0.0134	CbGeAlD
Amisulpride—Vaginal infection—Temozolomide—malignant glioma	0.00842	0.0245	CcSEcCtD
Amisulpride—Gynaecomastia—Carmustine—malignant glioma	0.00826	0.024	CcSEcCtD
Amisulpride—DRD2—telencephalon—malignant glioma	0.00813	0.0126	CbGeAlD
Amisulpride—HTR7—medulla oblongata—malignant glioma	0.00676	0.0105	CbGeAlD
Amisulpride—HTR2A—embryo—malignant glioma	0.00659	0.0103	CbGeAlD
Amisulpride—HTR7—midbrain—malignant glioma	0.00618	0.0096	CbGeAlD
Amisulpride—HTR2A—brainstem—malignant glioma	0.00604	0.0094	CbGeAlD
Amisulpride—HTR7—spinal cord—malignant glioma	0.00603	0.00937	CbGeAlD
Amisulpride—DRD2—midbrain—malignant glioma	0.00584	0.00908	CbGeAlD
Amisulpride—HTR2A—retina—malignant glioma	0.00583	0.00906	CbGeAlD
Amisulpride—HTR2B—central nervous system—malignant glioma	0.00571	0.00887	CbGeAlD
Amisulpride—Sweating increased—Temozolomide—malignant glioma	0.00545	0.0159	CcSEcCtD
Amisulpride—Neutropenia—Carmustine—malignant glioma	0.00541	0.0158	CcSEcCtD
Amisulpride—HTR2A—telencephalon—malignant glioma	0.00536	0.00834	CbGeAlD
Amisulpride—Neutropenia—Temozolomide—malignant glioma	0.00523	0.0152	CcSEcCtD
Amisulpride—Hyperglycaemia—Carmustine—malignant glioma	0.00522	0.0152	CcSEcCtD
Amisulpride—Erectile dysfunction—Temozolomide—malignant glioma	0.00515	0.015	CcSEcCtD
Amisulpride—Depression—Carmustine—malignant glioma	0.00515	0.015	CcSEcCtD
Amisulpride—Weight increased—Temozolomide—malignant glioma	0.00509	0.0148	CcSEcCtD
Amisulpride—Weight decreased—Temozolomide—malignant glioma	0.00506	0.0147	CcSEcCtD
Amisulpride—Neuropathy peripheral—Carmustine—malignant glioma	0.00506	0.0147	CcSEcCtD
Amisulpride—Hyperglycaemia—Temozolomide—malignant glioma	0.00505	0.0147	CcSEcCtD
Amisulpride—Depression—Temozolomide—malignant glioma	0.00497	0.0145	CcSEcCtD
Amisulpride—Neuropathy peripheral—Temozolomide—malignant glioma	0.00489	0.0142	CcSEcCtD
Amisulpride—HTR7—central nervous system—malignant glioma	0.00489	0.0076	CbGeAlD
Amisulpride—HTR7—cerebellum—malignant glioma	0.00478	0.00743	CbGeAlD
Amisulpride—DRD2—central nervous system—malignant glioma	0.00462	0.00719	CbGeAlD
Amisulpride—HTR2B—brain—malignant glioma	0.00453	0.00705	CbGeAlD
Amisulpride—DRD2—cerebellum—malignant glioma	0.00452	0.00702	CbGeAlD
Amisulpride—HTR2A—medulla oblongata—malignant glioma	0.00421	0.00655	CbGeAlD
Amisulpride—Cardiac disorder—Temozolomide—malignant glioma	0.00416	0.0121	CcSEcCtD
Amisulpride—Angiopathy—Temozolomide—malignant glioma	0.00406	0.0118	CcSEcCtD
Amisulpride—Mental disorder—Carmustine—malignant glioma	0.00406	0.0118	CcSEcCtD
Amisulpride—Immune system disorder—Temozolomide—malignant glioma	0.00405	0.0118	CcSEcCtD
Amisulpride—Malnutrition—Carmustine—malignant glioma	0.00403	0.0118	CcSEcCtD
Amisulpride—Mental disorder—Temozolomide—malignant glioma	0.00392	0.0114	CcSEcCtD
Amisulpride—Malnutrition—Temozolomide—malignant glioma	0.0039	0.0114	CcSEcCtD
Amisulpride—HTR7—brain—malignant glioma	0.00388	0.00603	CbGeAlD
Amisulpride—HTR2A—midbrain—malignant glioma	0.00385	0.00599	CbGeAlD
Amisulpride—Tremor—Carmustine—malignant glioma	0.00378	0.011	CcSEcCtD
Amisulpride—HTR2A—spinal cord—malignant glioma	0.00376	0.00584	CbGeAlD
Amisulpride—Agitation—Carmustine—malignant glioma	0.00371	0.0108	CcSEcCtD
Amisulpride—DRD2—brain—malignant glioma	0.00367	0.0057	CbGeAlD
Amisulpride—Tremor—Temozolomide—malignant glioma	0.00365	0.0106	CcSEcCtD
Amisulpride—Leukopenia—Carmustine—malignant glioma	0.00361	0.0105	CcSEcCtD
Amisulpride—Agitation—Temozolomide—malignant glioma	0.00358	0.0104	CcSEcCtD
Amisulpride—Angioedema—Temozolomide—malignant glioma	0.00356	0.0104	CcSEcCtD
Amisulpride—Convulsion—Carmustine—malignant glioma	0.0035	0.0102	CcSEcCtD
Amisulpride—Leukopenia—Temozolomide—malignant glioma	0.00349	0.0102	CcSEcCtD
Amisulpride—Hypertension—Carmustine—malignant glioma	0.00348	0.0101	CcSEcCtD
Amisulpride—Anxiety—Carmustine—malignant glioma	0.00342	0.00997	CcSEcCtD
Amisulpride—Convulsion—Temozolomide—malignant glioma	0.00338	0.00984	CcSEcCtD
Amisulpride—Hypertension—Temozolomide—malignant glioma	0.00337	0.0098	CcSEcCtD
Amisulpride—Anxiety—Temozolomide—malignant glioma	0.00331	0.00963	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0033	0.0096	CcSEcCtD
Amisulpride—Dry mouth—Temozolomide—malignant glioma	0.00325	0.00945	CcSEcCtD
Amisulpride—Nervous system disorder—Temozolomide—malignant glioma	0.00312	0.00909	CcSEcCtD
Amisulpride—Skin disorder—Temozolomide—malignant glioma	0.00309	0.009	CcSEcCtD
Amisulpride—Hypotension—Carmustine—malignant glioma	0.00308	0.00896	CcSEcCtD
Amisulpride—Hyperhidrosis—Temozolomide—malignant glioma	0.00308	0.00896	CcSEcCtD
Amisulpride—HTR2A—central nervous system—malignant glioma	0.00305	0.00474	CbGeAlD
Amisulpride—HTR2A—cerebellum—malignant glioma	0.00298	0.00463	CbGeAlD
Amisulpride—Insomnia—Carmustine—malignant glioma	0.00298	0.00867	CcSEcCtD
Amisulpride—Somnolence—Carmustine—malignant glioma	0.00293	0.00853	CcSEcCtD
Amisulpride—Insomnia—Temozolomide—malignant glioma	0.00288	0.00838	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Carmustine—malignant glioma	0.00284	0.00828	CcSEcCtD
Amisulpride—Somnolence—Temozolomide—malignant glioma	0.00283	0.00824	CcSEcCtD
Amisulpride—Constipation—Carmustine—malignant glioma	0.00282	0.0082	CcSEcCtD
Amisulpride—Dyspepsia—Temozolomide—malignant glioma	0.0028	0.00816	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00275	0.008	CcSEcCtD
Amisulpride—Fatigue—Temozolomide—malignant glioma	0.00274	0.00799	CcSEcCtD
Amisulpride—Constipation—Temozolomide—malignant glioma	0.00272	0.00792	CcSEcCtD
Amisulpride—Gastrointestinal pain—Carmustine—malignant glioma	0.00269	0.00784	CcSEcCtD
Amisulpride—Abdominal pain—Carmustine—malignant glioma	0.0026	0.00758	CcSEcCtD
Amisulpride—Gastrointestinal pain—Temozolomide—malignant glioma	0.0026	0.00758	CcSEcCtD
Amisulpride—Urticaria—Temozolomide—malignant glioma	0.00253	0.00736	CcSEcCtD
Amisulpride—Abdominal pain—Temozolomide—malignant glioma	0.00252	0.00733	CcSEcCtD
Amisulpride—Hypersensitivity—Carmustine—malignant glioma	0.00243	0.00707	CcSEcCtD
Amisulpride—HTR2A—brain—malignant glioma	0.00242	0.00376	CbGeAlD
Amisulpride—Asthenia—Carmustine—malignant glioma	0.00236	0.00688	CcSEcCtD
Amisulpride—Hypersensitivity—Temozolomide—malignant glioma	0.00234	0.00683	CcSEcCtD
Amisulpride—Asthenia—Temozolomide—malignant glioma	0.00228	0.00665	CcSEcCtD
Amisulpride—Diarrhoea—Carmustine—malignant glioma	0.00225	0.00656	CcSEcCtD
Amisulpride—Pruritus—Temozolomide—malignant glioma	0.00225	0.00656	CcSEcCtD
Amisulpride—Dizziness—Carmustine—malignant glioma	0.00218	0.00634	CcSEcCtD
Amisulpride—Diarrhoea—Temozolomide—malignant glioma	0.00218	0.00634	CcSEcCtD
Amisulpride—Dizziness—Temozolomide—malignant glioma	0.0021	0.00613	CcSEcCtD
Amisulpride—Vomiting—Carmustine—malignant glioma	0.00209	0.0061	CcSEcCtD
Amisulpride—Headache—Carmustine—malignant glioma	0.00206	0.00601	CcSEcCtD
Amisulpride—Vomiting—Temozolomide—malignant glioma	0.00202	0.00589	CcSEcCtD
Amisulpride—Headache—Temozolomide—malignant glioma	0.00199	0.00581	CcSEcCtD
Amisulpride—Nausea—Carmustine—malignant glioma	0.00196	0.0057	CcSEcCtD
Amisulpride—Nausea—Temozolomide—malignant glioma	0.00189	0.0055	CcSEcCtD
Amisulpride—HTR2B—Signaling Pathways—TERT—malignant glioma	1.42e-06	0.000594	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CG—malignant glioma	1.42e-06	0.000593	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PTPN11—malignant glioma	1.42e-06	0.000592	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOTCH2—malignant glioma	1.41e-06	0.000589	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CD—malignant glioma	1.4e-06	0.000584	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PTPN11—malignant glioma	1.4e-06	0.000583	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SPP1—malignant glioma	1.4e-06	0.000583	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCL8—malignant glioma	1.39e-06	0.00058	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PDGFB—malignant glioma	1.39e-06	0.00058	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH2—malignant glioma	1.39e-06	0.000579	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGFR1—malignant glioma	1.38e-06	0.000577	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KNG1—malignant glioma	1.38e-06	0.000576	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CD—malignant glioma	1.38e-06	0.000574	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FN1—malignant glioma	1.37e-06	0.000572	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—F2—malignant glioma	1.37e-06	0.000572	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HIF1A—malignant glioma	1.36e-06	0.000568	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KNG1—malignant glioma	1.36e-06	0.000567	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—BAD—malignant glioma	1.35e-06	0.000565	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOTCH1—malignant glioma	1.34e-06	0.00056	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL2—malignant glioma	1.33e-06	0.000555	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TERT—malignant glioma	1.32e-06	0.000553	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT2—malignant glioma	1.32e-06	0.000552	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CAV1—malignant glioma	1.32e-06	0.000549	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NTRK1—malignant glioma	1.31e-06	0.000549	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CD80—malignant glioma	1.31e-06	0.000549	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APC—malignant glioma	1.31e-06	0.000548	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CG—malignant glioma	1.31e-06	0.000548	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KDR—malignant glioma	1.3e-06	0.000543	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT2—malignant glioma	1.3e-06	0.000543	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGF—malignant glioma	1.3e-06	0.000541	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NTRK1—malignant glioma	1.29e-06	0.00054	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PDGFB—malignant glioma	1.29e-06	0.000539	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTPN11—malignant glioma	1.29e-06	0.000538	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGFR1—malignant glioma	1.28e-06	0.000537	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CD—malignant glioma	1.27e-06	0.00053	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HIF1A—malignant glioma	1.27e-06	0.000528	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—F2—malignant glioma	1.25e-06	0.000523	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FN1—malignant glioma	1.25e-06	0.000523	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CD—malignant glioma	1.25e-06	0.000522	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—BAD—malignant glioma	1.24e-06	0.000517	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—BRAF—malignant glioma	1.23e-06	0.000515	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOTCH1—malignant glioma	1.23e-06	0.000512	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CAV1—malignant glioma	1.22e-06	0.000511	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP3—malignant glioma	1.22e-06	0.00051	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CB—malignant glioma	1.22e-06	0.000509	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN2B—malignant glioma	1.21e-06	0.000506	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KDR—malignant glioma	1.21e-06	0.000505	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP3—malignant glioma	1.2e-06	0.000502	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CD80—malignant glioma	1.2e-06	0.000501	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT2—malignant glioma	1.2e-06	0.000501	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CB—malignant glioma	1.2e-06	0.000501	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CG—malignant glioma	1.2e-06	0.0005	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APC—malignant glioma	1.2e-06	0.0005	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—EGFR—malignant glioma	1.19e-06	0.000499	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN2B—malignant glioma	1.19e-06	0.000498	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGF—malignant glioma	1.18e-06	0.000495	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTPN11—malignant glioma	1.18e-06	0.000492	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTK2—malignant glioma	1.18e-06	0.000491	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	1.17e-06	0.000489	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FN1—malignant glioma	1.17e-06	0.000486	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—F2—malignant glioma	1.17e-06	0.000486	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTK2—malignant glioma	1.16e-06	0.000483	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HES1—malignant glioma	1.16e-06	0.000483	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CD—malignant glioma	1.15e-06	0.000481	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL8—malignant glioma	1.15e-06	0.000481	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BAD—malignant glioma	1.15e-06	0.000481	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NCOR1—malignant glioma	1.15e-06	0.00048	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PIK3CA—malignant glioma	1.14e-06	0.000477	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOTCH1—malignant glioma	1.14e-06	0.000476	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HES1—malignant glioma	1.14e-06	0.000475	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—RAF1—malignant glioma	1.13e-06	0.000473	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NCOR1—malignant glioma	1.13e-06	0.000472	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—KRAS—malignant glioma	1.13e-06	0.000471	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—BRAF—malignant glioma	1.13e-06	0.00047	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—IL2—malignant glioma	1.12e-06	0.000467	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CD80—malignant glioma	1.12e-06	0.000466	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—RAF1—malignant glioma	1.12e-06	0.000466	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APC—malignant glioma	1.11e-06	0.000466	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CG—malignant glioma	1.11e-06	0.000466	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	1.11e-06	0.000462	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGF2—malignant glioma	1.1e-06	0.000461	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGF—malignant glioma	1.1e-06	0.00046	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—IL2—malignant glioma	1.1e-06	0.00046	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PDGFRA—malignant glioma	1.1e-06	0.000459	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT2—malignant glioma	1.1e-06	0.000458	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTPN11—malignant glioma	1.1e-06	0.000457	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—EGFR—malignant glioma	1.09e-06	0.000456	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CB—malignant glioma	1.09e-06	0.000455	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PDGFRA—malignant glioma	1.08e-06	0.000452	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SPP1—malignant glioma	1.07e-06	0.000446	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL8—malignant glioma	1.06e-06	0.000444	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	1.05e-06	0.00044	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SPP1—malignant glioma	1.05e-06	0.000439	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BRAF—malignant glioma	1.05e-06	0.000438	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL8—malignant glioma	1.05e-06	0.000437	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	1.04e-06	0.000436	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—malignant glioma	1.04e-06	0.000433	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MDM2—malignant glioma	1.03e-06	0.000431	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—KRAS—malignant glioma	1.03e-06	0.000431	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RAF1—malignant glioma	1.03e-06	0.00043	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT2—malignant glioma	1.02e-06	0.000426	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ERBB2—malignant glioma	1.02e-06	0.000425	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2—malignant glioma	1.02e-06	0.000424	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—malignant glioma	1.02e-06	0.000424	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TERT—malignant glioma	1.01e-06	0.000423	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGF2—malignant glioma	1.01e-06	0.000421	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CB—malignant glioma	1e-06	0.00042	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2—malignant glioma	1e-06	0.000418	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TERT—malignant glioma	9.96e-07	0.000416	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PDGFB—malignant glioma	9.88e-07	0.000413	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGFR1—malignant glioma	9.83e-07	0.000411	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CD—malignant glioma	9.8e-07	0.000409	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PDGFB—malignant glioma	9.72e-07	0.000406	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—malignant glioma	9.71e-07	0.000405	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HIF1A—malignant glioma	9.68e-07	0.000404	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGFR1—malignant glioma	9.67e-07	0.000404	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL8—malignant glioma	9.66e-07	0.000403	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—KRAS—malignant glioma	9.6e-07	0.000401	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HIF1A—malignant glioma	9.53e-07	0.000398	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	9.47e-07	0.000396	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MDM2—malignant glioma	9.44e-07	0.000394	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RAF1—malignant glioma	9.4e-07	0.000393	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGF2—malignant glioma	9.38e-07	0.000392	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CAV1—malignant glioma	9.37e-07	0.000391	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—malignant glioma	9.33e-07	0.000389	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ERBB2—malignant glioma	9.3e-07	0.000388	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KDR—malignant glioma	9.26e-07	0.000387	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—malignant glioma	9.24e-07	0.000386	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2—malignant glioma	9.23e-07	0.000385	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CAV1—malignant glioma	9.22e-07	0.000385	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	9.18e-07	0.000383	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KDR—malignant glioma	9.11e-07	0.000381	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—F2—malignant glioma	8.91e-07	0.000372	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FN1—malignant glioma	8.91e-07	0.000372	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL8—malignant glioma	8.82e-07	0.000368	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—malignant glioma	8.82e-07	0.000368	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BAD—malignant glioma	8.81e-07	0.000368	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MDM2—malignant glioma	8.78e-07	0.000367	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—F2—malignant glioma	8.77e-07	0.000366	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FN1—malignant glioma	8.77e-07	0.000366	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RAF1—malignant glioma	8.75e-07	0.000365	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—malignant glioma	8.73e-07	0.000365	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOTCH1—malignant glioma	8.72e-07	0.000364	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTEN—malignant glioma	8.68e-07	0.000363	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BAD—malignant glioma	8.67e-07	0.000362	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ERBB2—malignant glioma	8.66e-07	0.000361	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	8.58e-07	0.000358	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CD80—malignant glioma	8.55e-07	0.000357	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CB—malignant glioma	8.54e-07	0.000357	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APC—malignant glioma	8.53e-07	0.000356	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—malignant glioma	8.53e-07	0.000356	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	8.52e-07	0.000356	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—malignant glioma	8.47e-07	0.000354	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—malignant glioma	8.44e-07	0.000353	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGF—malignant glioma	8.43e-07	0.000352	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2—malignant glioma	8.43e-07	0.000352	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CD80—malignant glioma	8.41e-07	0.000351	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APC—malignant glioma	8.39e-07	0.000351	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	8.39e-07	0.000351	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTPN11—malignant glioma	8.38e-07	0.00035	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGF—malignant glioma	8.3e-07	0.000346	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTPN11—malignant glioma	8.25e-07	0.000344	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL8—malignant glioma	8.21e-07	0.000343	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BRAF—malignant glioma	8.02e-07	0.000335	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—malignant glioma	7.98e-07	0.000333	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTEN—malignant glioma	7.93e-07	0.000331	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—malignant glioma	7.93e-07	0.000331	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BRAF—malignant glioma	7.89e-07	0.000329	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—malignant glioma	7.86e-07	0.000328	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2—malignant glioma	7.85e-07	0.000328	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—malignant glioma	7.84e-07	0.000327	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT2—malignant glioma	7.81e-07	0.000326	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—malignant glioma	7.77e-07	0.000325	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—malignant glioma	7.76e-07	0.000324	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—malignant glioma	7.74e-07	0.000323	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT2—malignant glioma	7.68e-07	0.000321	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—malignant glioma	7.65e-07	0.000319	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CD—malignant glioma	7.5e-07	0.000313	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	7.43e-07	0.00031	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—malignant glioma	7.43e-07	0.00031	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTEN—malignant glioma	7.38e-07	0.000308	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	7.38e-07	0.000308	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—KRAS—malignant glioma	7.34e-07	0.000307	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	7.31e-07	0.000305	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—KRAS—malignant glioma	7.23e-07	0.000302	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—malignant glioma	7.22e-07	0.000301	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—malignant glioma	7.2e-07	0.000301	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGF2—malignant glioma	7.18e-07	0.0003	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—malignant glioma	7.17e-07	0.000299	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—malignant glioma	7.1e-07	0.000296	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGF2—malignant glioma	7.07e-07	0.000295	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—malignant glioma	7.06e-07	0.000295	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	6.75e-07	0.000282	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MDM2—malignant glioma	6.72e-07	0.000281	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RAF1—malignant glioma	6.7e-07	0.00028	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—malignant glioma	6.67e-07	0.000278	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KRAS—malignant glioma	6.67e-07	0.000278	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	6.64e-07	0.000277	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB2—malignant glioma	6.62e-07	0.000277	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MDM2—malignant glioma	6.61e-07	0.000276	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—malignant glioma	6.6e-07	0.000276	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—malignant glioma	6.59e-07	0.000275	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RAF1—malignant glioma	6.59e-07	0.000275	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CB—malignant glioma	6.54e-07	0.000273	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB2—malignant glioma	6.52e-07	0.000272	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—malignant glioma	6.45e-07	0.000269	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	6.43e-07	0.000269	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL8—malignant glioma	6.28e-07	0.000262	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL8—malignant glioma	6.18e-07	0.000258	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—malignant glioma	6.13e-07	0.000256	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—malignant glioma	6.13e-07	0.000256	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KRAS—malignant glioma	6.09e-07	0.000254	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—malignant glioma	6.07e-07	0.000253	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—malignant glioma	6.01e-07	0.000251	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2—malignant glioma	6e-07	0.000251	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—malignant glioma	6e-07	0.000251	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	5.97e-07	0.000249	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—malignant glioma	5.93e-07	0.000247	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—malignant glioma	5.92e-07	0.000247	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2—malignant glioma	5.91e-07	0.000247	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—malignant glioma	5.68e-07	0.000237	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KRAS—malignant glioma	5.67e-07	0.000237	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTEN—malignant glioma	5.65e-07	0.000236	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	5.6e-07	0.000234	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—malignant glioma	5.59e-07	0.000233	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTEN—malignant glioma	5.56e-07	0.000232	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—malignant glioma	5.51e-07	0.00023	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—malignant glioma	5.42e-07	0.000226	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—malignant glioma	5.41e-07	0.000226	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—malignant glioma	5.21e-07	0.000217	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—malignant glioma	5.1e-07	0.000213	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—malignant glioma	5.05e-07	0.000211	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—malignant glioma	5.04e-07	0.00021	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—malignant glioma	5.02e-07	0.00021	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—malignant glioma	5e-07	0.000209	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—malignant glioma	4.97e-07	0.000208	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—malignant glioma	4.69e-07	0.000196	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—malignant glioma	4.62e-07	0.000193	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—malignant glioma	4.59e-07	0.000192	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—malignant glioma	4.57e-07	0.000191	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—malignant glioma	4.52e-07	0.000189	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KRAS—malignant glioma	4.34e-07	0.000181	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KRAS—malignant glioma	4.27e-07	0.000178	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—malignant glioma	4.25e-07	0.000178	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—malignant glioma	3.99e-07	0.000166	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	3.92e-07	0.000164	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—malignant glioma	3.86e-07	0.000161	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—malignant glioma	3.79e-07	0.000158	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—malignant glioma	3.26e-07	0.000136	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—malignant glioma	3.2e-07	0.000134	CbGpPWpGaD
